tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Abivax price target raised, named a ‘Best Idea’ at Guggenheim
PremiumThe FlyAbivax price target raised, named a ‘Best Idea’ at Guggenheim
29d ago
Abivax price target raised to $120 from $112 at BTIG
Premium
The Fly
Abivax price target raised to $120 from $112 at BTIG
1M ago
Abivax’s Obefazimod: Promising Clinical Results and Market Potential Drive Buy Rating
Premium
Ratings
Abivax’s Obefazimod: Promising Clinical Results and Market Potential Drive Buy Rating
1M ago
Abivax price target raised to $101 from $71 at Morgan Stanley
PremiumThe FlyAbivax price target raised to $101 from $71 at Morgan Stanley
2M ago
Abivax SA Reports Financial Results and Strategic Advances
Premium
Company Announcements
Abivax SA Reports Financial Results and Strategic Advances
2M ago
Promising Outlook for Abivax SA: Buy Rating Supported by Strong Clinical Results and Financial Position
Premium
Ratings
Promising Outlook for Abivax SA: Buy Rating Supported by Strong Clinical Results and Financial Position
2M ago
Abivax prices 10.2M ADSs at $64.00 in underwritten public offering
PremiumThe FlyAbivax prices 10.2M ADSs at $64.00 in underwritten public offering
4M ago
Abivax 10.16M ADS offering priced at $64.00
Premium
The Fly
Abivax 10.16M ADS offering priced at $64.00
4M ago
Abivax SA’s Obefazimod: Strong Phase 3 Results and Promising Market Potential Justify Buy Rating
Premium
Ratings
Abivax SA’s Obefazimod: Strong Phase 3 Results and Promising Market Potential Justify Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100